Devry Inc (DV) 20.80 $DV DEADLINE TOMORROW: Levi &

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Devry Inc (DV) 20.80 $DV

DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of DeVry Education Group, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 12, 2016 - DV
PR Newswire - Mon Jul 11, 9:46AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
DV: 20.80 (+0.39)

DEADLINE APPROACHING: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against DeVry Education Group Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 08, 3:16PM CDT
IRVINE, CA / ACCESSWIRE / July 8, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against DeVry Education Group Inc. ("DeVry" or the "Company" (NYSE: DV). Investors who purchased or otherwise acquired shares between February 4, 2011 and January 27, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 12, 2016 lead plaintiff motion deadline.
DV: 20.80 (+0.39)

DEADLINE ALERT - DeVry Education Group Inc. - Brower Piven Reminds Investors Of Upcoming Deadline And Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact The Firm - DV
GlobeNewswire - Fri Jul 08, 12:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf of purchasers of DeVry Education Group Inc. (NYSEV) ("DeVry" or the "Company" securities during the period between February 4, 2011 and January 27, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 12, 2016 to seek appointment as lead plaintiff.
DV: 20.80 (+0.39)

Apollo Education (APOL) Q3 Earnings & Revenues Beat
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:06AM CDT
Apollo Education's (APOL) adjusted earnings (excluding special items) of 37 cents per share in the third quarter of fiscal 2016 surpassed the Zacks Consensus Estimate of 28 cents by 32.14%.
LOPE: 41.76 (+1.38), APEI: 29.00 (+0.51), DV: 20.80 (+0.39), APOL: 9.08 (-0.03)

Zacks.com featured highlights: DeVry Education Group, PharMerica, Trinity Industries, Select Medical and Tower International
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 8:30AM CDT
Zacks.com featured highlights: DeVry Education Group, PharMerica, Trinity Industries, Select Medical and Tower International
PMC: 26.25 (+0.34), TRN: 20.90 (+0.70), DV: 20.80 (+0.39), TOWR: 21.41 (+0.49), SEM: 11.32 (+0.13)

IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against DeVry Education Group Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jul 07, 10:56AM CDT
LOS ANGELES, CA / ACCESSWIRE / July 7, 2016 / Lundin Law PC announces a class action lawsuit has been filed against DeVry Education Group Inc. ("DeVry" or the "Company" (NYSE: DV) concerning possible violations of federal securities laws between February 4, 2011 and January 27, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 12, 2016 lead plaintiff motion deadline.
DV: 20.80 (+0.39)

Hagens Berman Reminds DeVry Education Group Inc. (NYSE: DV) Investors of July 12, 2016 Lead Plaintiff Deadline
GlobeNewswire - Thu Jul 07, 8:30AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds DeVry Education Group Inc. (NYSEV) investors of the July 12, 2016 Lead Plaintiff Deadline in the securities class action filed in the United States District Court for the Northern District of Illinois.
DV: 20.80 (+0.39)

Zacks.com featured highlights: DeVry Education Group, Herbalife, Children's Place, Bruker and Expeditors International of Washington
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:30AM CDT
Zacks.com featured highlights: DeVry Education Group, Herbalife, Children's Place, Bruker and Expeditors International of Washington
HLF: 61.87 (+0.89), PLCE: 83.56 (+0.65), EXPD: 49.99 (+0.18), BRKR: 24.86 (+0.51), DV: 20.80 (+0.39)

5 Low Price-to-Cash-Flow Stocks for Assured Returns
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:29AM CDT
There are different valuation metrics to determine a stock's inherent strength but a random selection of ratios cannot serve your purpose.
PMC: 26.25 (+0.34), TRN: 20.90 (+0.70), DV: 20.80 (+0.39), SEM: 11.32 (+0.13), TOWR: 21.41 (+0.49)

DeVry Education (DV) Subsidiary Closes ACAMS Acquisition
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:54AM CDT
DeVry's subsidiary, Becker Professional Education closed its acquisition of the Association of Certified Anti-Money Laundering Specialists (ACAMS) for $330 million.
APEI: 29.00 (+0.51), CPLA: 56.16 (+1.27), DV: 20.80 (+0.39), APOL: 9.08 (-0.03)

5 Liquid Stocks to Enhance Your Portfolio Return
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 7:00AM CDT
A strategy that successfully identifies efficient companies with favorable liquidity positions is poised to provide impressive returns irrespective of market conditions.
HLF: 61.87 (+0.89), PLCE: 83.56 (+0.65), EXPD: 49.99 (+0.18), BRKR: 24.86 (+0.51), DV: 20.80 (+0.39)

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against DeVry Education Group Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Jul 05, 7:25PM CDT
IRVINE, CA / ACCESSWIRE / July 5, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against DeVry Education Group Inc. ("DeVry" or the "Company" (NYSE: DV). Investors who purchased or otherwise acquired shares between February 4, 2011 and January 27, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 12, 2016 lead plaintiff motion deadline.
DV: 20.80 (+0.39)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of DeVry Education Group, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 12, 2016 - DV
GlobeNewswire - Tue Jul 05, 10:41AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
DV: 20.80 (+0.39)

DeVry Education Group's Student Aid Modernization Initiative (SAMI) White Paper Proposes New Concept for Higher Education Act Reauthorization
BusinessWire - Tue Jul 05, 8:15AM CDT
A paper authored by DeVry Education Group's regulatory affairs manager Marcus Szymanoski proposes new concept for Higher Education Act (HEA) reauthorization. The paper, titled "Student Aid Modernization Initiative (SAMI): Transforming Federal Student Aid for the 21st Century," was the winner of the inaugural "Big Idea" policy proposal competition at the National Association of Student Financial Aid Administrators (NASFAA) national conference in New Orleans in 2015.
DV: 20.80 (+0.39)

Zacks.com featured highlights: DeVry Education Group, Trinity Industries, CVR Refining, Standard Motor Products and Korea Electric Power
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 8:30AM CDT
Zacks.com featured highlights: DeVry Education Group, Trinity Industries, CVR Refining, Standard Motor Products and Korea Electric Power
KEP: 26.07 (-0.37), SMP: 41.20 (+0.08), TRN: 20.90 (+0.70), DV: 20.80 (+0.39), CVRR: 6.66 (-0.07)

5 Low Price-to-Sales Stocks Poised for Big Returns
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:35AM CDT
Price-to-Sales is often preferred to Price-to-Earnings, as companies and managements can fiddle with their earnings using various accounting measures.
SMP: 41.20 (+0.08), KEP: 26.07 (-0.37), TRN: 20.90 (+0.70), DV: 20.80 (+0.39), CVRR: 6.66 (-0.07)

SmarTrend Watching for Potential Rebound in Shares of DeVry After 1.44% Loss
Comtex SmarTrend(R) - Tue Jun 28, 3:30PM CDT
DeVry (NYSEV) traded in a range yesterday that spanned from a low of $16.63 to a high of $17.20. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $16.92 on volume of 290,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DV: 20.80 (+0.39)

Kessler Topaz Meltzer & Check, LLP Reminds DeVry Education Group, Inc. Shareholders of Important Deadline in Class Action Lawsuit
BusinessWire - Mon Jun 27, 8:00AM CDT
The law firm of Kessler Topaz Meltzer & Check, LLP reminds DeVry Education Group, Inc. (NYSE: DV) ("DeVry" or the "Company" shareholders that a class action lawsuit has been filed on behalf of purchasers of the Company's securities between February 4, 2011 and January 27, 2016, inclusive (the "Class Period".
DV: 20.80 (+0.39)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving DeVry Education Group, Inc. and a Lead Plaintiff Deadline of July 12, 2016 - DV
BusinessWire - Fri Jun 24, 9:42AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of Illinois on behalf of investors who purchased DeVry Education Group, Inc. (NYSE: DV) securities between February 4, 2011 and January 27, 2016.
DV: 20.80 (+0.39)

Shareholder Lawsuit Filed Against DeVry Education Group, Inc.
ACCESSWIRE - Thu Jun 23, 12:28PM CDT
RADNOR, PA / ACCESSWIRE / June 23, 2016 / The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against DeVry Education Group, Inc. (NYSE: DV) ("DeVry" or the "Company" on behalf of purchasers of the Company's securities between February 4, 2011 and January 27, 2016, inclusive (the "Class Period".
DV: 20.80 (+0.39)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nokia Corporation's Recent Management Transaction Highlights

Updated Category News Views 135

Nokia Corporation's Latest Management Transactions Nokia Corporation has recently announced significant management transactions that emphasize its ongoing operational strategies and technological innovations. Today, we dive into the details of one particular transaction involving a key manager in the company. Transaction Details This transaction notification is made under...

Continue Reading
Huawei's Innovative AI WAN Solution Revolutionizes Networking

Updated Category News Views 262

Huawei's New AI WAN Solution Unveiled At the Mobile World Congress in Barcelona, Huawei introduced the AI WAN Solution, a groundbreaking development designed to revolutionize networking. Leon Wang, the President of Huawei's Data Communication Product Line, emphasized the importance of merging AI with network infrastructures. This new solution aims to enhance IP networks...

Continue Reading
Transforming Business Dreams with Innovative Software Solutions

Updated Category News Views 114

Transforming Business Dreams with Innovative Software Solutions FM, a pioneer in custom software development augmented by AI technology, is revolutionizing how businesses approach growth and scalability. In a rapidly changing landscape, where adaptability is key, FM’s approach enables organizations to leverage generative software solutions that are more accessible than...

Continue Reading
Investment in Caesars Palace Times Square Promises Growth

Updated Category News Views 171

Community Investment and Support for Caesars Palace Times Square During a recent public hearing, community support was overwhelmingly evident for the Caesars Palace Times Square project. Local residents, small business owners, union workers, and city leaders gathered to express their enthusiasm for a project that promises to generate significant economic growth and create...

Continue Reading
Aquestive Therapeutics Reaches Milestone with FDA Notification

Updated Category News Views 114

Groundbreaking News from Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST), a forward-thinking pharmaceutical company dedicated to enhancing patient care through innovative drug delivery solutions, has officially received word from the U.S. Food and Drug Administration (FDA) that no advisory committee meeting will be required for the New Drug Application...

Continue Reading